Zentek (ZTEK) Non Operating Investment Income (2025 - 2026)
Zentek (ZTEK) posted quarterly Non Operating Investment Income of -$10009.8 for Q1 2026, down 102.86% on a QoQ basis from $350532.6 in Q4 2025.
Zentek (ZTEK) Non Operating Investment Income (2025 - 2026) Analysis & Trends
Zentek (ZTEK) has reported Non Operating Investment Income for 2 consecutive years, with -$10009.8 the latest figure, recorded in Q1 2026.
- Quarterly Non Operating Investment Income changed N/A year-over-year to -$10009.8 in Q1 2026, while the trailing twelve-month figure through Dec 2025 was $350532.6 (changed N/A YoY) and the FY2026 annual result came in at $283744.7, up 2812.06% from the prior year.
- Non Operating Investment Income declined to -$10009.8 in Q1 2026 per ZTEK's latest filing, from $350532.6 in the prior quarter.
- Over the last five years, Non Operating Investment Income for ZTEK reached as high as $352794.0 in Q2 2025 and fell as low as -$10009.8 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.05 Bn | 120.83 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 44.78 Bn | 43.96 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.95 Bn | 31.30 Bn | 1.53 Bn | - |
| 4 | Medline | 32.84 Bn | 30.60 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | -10.13 Mn |
| 6 | West Pharmaceutical Services | 23.59 Bn | 23.15 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.02 Bn | 13.45 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.77 Bn | 13.64 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | - |
| 10 | Zentek | 61.01 Mn | 60.06 Mn | -979,642.64 | -10,009.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,009.81 |
| Mar 31, 2026 | -10,009.81 |
| Dec 31, 2025 | 350,532.57 |
| Dec 31, 2025 | 350,532.57 |
| Sep 30, 2025 | -9,775.42 |
| Sep 30, 2025 | -9,775.42 |
| Jun 30, 2025 | 352,794.00 |
| Jun 30, 2025 | 352,794.00 |